Cargando…
PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Background: Autosomal dominant polycystic kidney disease (ADPKD) occurs in 1 in 500–4000 people worldwide. Genetic mutation is a biomarker for predicting renal dysfunction in patients with ADPKD. In this study, we performed a genetic analysis of Japanese patients with ADPKD to investigate the progno...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377076/ https://www.ncbi.nlm.nih.gov/pubmed/37509056 http://dx.doi.org/10.3390/biom13071020 |
_version_ | 1785079427041853440 |
---|---|
author | Kimura, Tomoki Kawano, Haruna Muto, Satoru Muramoto, Nobuhito Takano, Toshiaki Lu, Yan Eguchi, Hidetaka Wada, Hiroo Okazaki, Yasushi Ide, Hisamitsu Horie, Shigeo |
author_facet | Kimura, Tomoki Kawano, Haruna Muto, Satoru Muramoto, Nobuhito Takano, Toshiaki Lu, Yan Eguchi, Hidetaka Wada, Hiroo Okazaki, Yasushi Ide, Hisamitsu Horie, Shigeo |
author_sort | Kimura, Tomoki |
collection | PubMed |
description | Background: Autosomal dominant polycystic kidney disease (ADPKD) occurs in 1 in 500–4000 people worldwide. Genetic mutation is a biomarker for predicting renal dysfunction in patients with ADPKD. In this study, we performed a genetic analysis of Japanese patients with ADPKD to investigate the prognostic utility of genetic mutations in predicting renal function outcomes. Methods: Patients clinically diagnosed with ADPKD underwent a panel genetic test for germline mutations in PKD1 and PKD2. This study was conducted with the approval of the Ethics Committee of Juntendo University (no. 2019107). Results: Of 436 patients, 366 (83.9%) had genetic mutations. Notably, patients with PKD1 mutation had a significantly decreased ΔeGFR/year compared to patients with PKD2 mutation, indicating a progression of renal dysfunction (−3.50 vs. −2.04 mL/min/1.73 m(2)/year, p = 0.066). Furthermore, PKD1 truncated mutations had a significantly decreased ΔeGFR/year compared to PKD1 non-truncated mutations in the population aged over 65 years (−6.56 vs. −2.16 mL/min/1.73 m(2)/year, p = 0.049). Multivariate analysis showed that PKD1 mutation was a more significant risk factor than PKD2 mutation (odds ratio, 1.81; 95% confidence interval, 1.11–3.16; p = 0.020). Conclusions: The analysis of germline mutations can predict renal prognosis in Japanese patients with ADPKD, and PKD1 mutation is a biomarker of ADPKD. |
format | Online Article Text |
id | pubmed-10377076 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103770762023-07-29 PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease Kimura, Tomoki Kawano, Haruna Muto, Satoru Muramoto, Nobuhito Takano, Toshiaki Lu, Yan Eguchi, Hidetaka Wada, Hiroo Okazaki, Yasushi Ide, Hisamitsu Horie, Shigeo Biomolecules Article Background: Autosomal dominant polycystic kidney disease (ADPKD) occurs in 1 in 500–4000 people worldwide. Genetic mutation is a biomarker for predicting renal dysfunction in patients with ADPKD. In this study, we performed a genetic analysis of Japanese patients with ADPKD to investigate the prognostic utility of genetic mutations in predicting renal function outcomes. Methods: Patients clinically diagnosed with ADPKD underwent a panel genetic test for germline mutations in PKD1 and PKD2. This study was conducted with the approval of the Ethics Committee of Juntendo University (no. 2019107). Results: Of 436 patients, 366 (83.9%) had genetic mutations. Notably, patients with PKD1 mutation had a significantly decreased ΔeGFR/year compared to patients with PKD2 mutation, indicating a progression of renal dysfunction (−3.50 vs. −2.04 mL/min/1.73 m(2)/year, p = 0.066). Furthermore, PKD1 truncated mutations had a significantly decreased ΔeGFR/year compared to PKD1 non-truncated mutations in the population aged over 65 years (−6.56 vs. −2.16 mL/min/1.73 m(2)/year, p = 0.049). Multivariate analysis showed that PKD1 mutation was a more significant risk factor than PKD2 mutation (odds ratio, 1.81; 95% confidence interval, 1.11–3.16; p = 0.020). Conclusions: The analysis of germline mutations can predict renal prognosis in Japanese patients with ADPKD, and PKD1 mutation is a biomarker of ADPKD. MDPI 2023-06-21 /pmc/articles/PMC10377076/ /pubmed/37509056 http://dx.doi.org/10.3390/biom13071020 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kimura, Tomoki Kawano, Haruna Muto, Satoru Muramoto, Nobuhito Takano, Toshiaki Lu, Yan Eguchi, Hidetaka Wada, Hiroo Okazaki, Yasushi Ide, Hisamitsu Horie, Shigeo PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title | PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title_full | PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title_fullStr | PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title_full_unstemmed | PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title_short | PKD1 Mutation Is a Biomarker for Autosomal Dominant Polycystic Kidney Disease |
title_sort | pkd1 mutation is a biomarker for autosomal dominant polycystic kidney disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377076/ https://www.ncbi.nlm.nih.gov/pubmed/37509056 http://dx.doi.org/10.3390/biom13071020 |
work_keys_str_mv | AT kimuratomoki pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT kawanoharuna pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT mutosatoru pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT muramotonobuhito pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT takanotoshiaki pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT luyan pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT eguchihidetaka pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT wadahiroo pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT okazakiyasushi pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT idehisamitsu pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease AT horieshigeo pkd1mutationisabiomarkerforautosomaldominantpolycystickidneydisease |